Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 583 of 6351
-
Can surgery and radiation tame spread of HER2+ breast cancer?
Disease control Recruiting nowThe researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treating oligometastatic HER2-positive breast cancer than the usual approach alone. T…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo aims to fight tough breast cancer
Disease control Recruiting nowThis is an open-label, multi-center, phase II clinical study to preliminarily evaluate the efficacy and safety of JS207 combined with 9MW2821 or albumin paclitaxel as first-line therapy in patients with recurrent or metastatic TNBC.
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New cell therapy takes on Hard-to-Treat myeloma
Disease control Recruiting nowA prospective, single-arm, open-label dose-exploration and expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor efficacy characteristics of LCAR-F33S in patients with relapsed/refractory multiple myeloma(Investigator-initiated Study).
Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Nasal spray could tame brain inflammation in early Alzheimer's
Disease control Recruiting nowThis phase 2a study will research the safety and tolerability of Foralumab, a human anti-CD3 antibody. An antibody is a molecule secreted by the immune system. These molecules are created to identify a specific pathogen. Previous data on experimental mice has suggested that Foral…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New CIDP drug empasiprubart enters final phase of testing
Disease control Recruiting nowThe main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B …
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can an app save lives from overdose? philly trial aims to find out
Disease control Recruiting nowThe goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are: Hypothesis 1: UnityPhilly signal rates relative to EM…
Sponsor: Drexel University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New shot could tame COPD Flare-Ups for those with eosinophilic lung disease
Disease control Recruiting nowThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pul…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktail aims to wipe out myeloma cells in newly diagnosed patients
Disease control Recruiting nowThe purpose of this study is to determine the effects that Elranatamab in combination with Lenalidomide and Dexamethasone has on participants that have been newly diagnosed with Multiple Myeloma.
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to beat leukemia in patients too frail for standard chemo
Disease control Recruiting nowThis phase II trial tests how well VA alternating with low-dose CHA works in treating unfit patients with newly diagnosed acute myeloid leukemia (AML). This is a prospective, multi-centers, single arm phase II study aimed to overcome VEN resistance and achieve greater MRD negativ…
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
No bubble needed? new eye surgery could change macular hole repair
Symptom relief Recruiting nowFull-thickness macular hole (MH) is a common sight threatening macular condition with a prevalence of 3.3 per 1000 individuals. Prompt surgical repair of MH is imperative in preventing irreversible vision loss from MH as the majority of patients would experience progressive loss …
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Could a 20% lower anesthetic dose make C-Sections safer?
Disease control Recruiting nowEffect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Phase 4 • Sponsor: Aswan University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New daily pill could ease knee pain and help weight loss in obesity
Symptom relief Recruiting nowThe GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last abo…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Chilled magnesium may boost stroke recovery in new trial
Disease control By invitation onlyThe primary objective of this study is to estimate the safety and effectiveness of selective intra-arterial hypothermic magnesium sulfate infusion after endovascular thrombectomy in patients with acute ischemic stroke. Addendum regarding phase 1 dosing implementation and planned…
Phase 1/2 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for Hard-to-Treat depression in seniors: esketamine spray vs aripiprazole
Symptom relief Not yet recruitingPhase III, open label, randomised, multicentre, blind for evaluators clinical trial to evaluate the efficacy of esketamine nasal spray at flexible dosis compared to aripiprazole in elderly participants (\>60 years) who suffer from treatment-resistant major depressive
Phase 3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 26, 2026 13:33 UTC
-
New malaria vaccine trial aims to block the parasite at multiple stages
Vaccine Recruiting nowThis is a Phase Ib age de-escalation, dose escalation, open-label study to assess the safety and immunogenicity of the multi-stage malaria vaccine candidate R21 plus RH5.1 and/or R78C in Matrix-M in adults aged 18-35 years and children aged 5-17 months in Burkina Faso.
Phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 11:01 UTC
-
New adaptive chemo strategy aims to outsmart advanced breast cancer
Disease control Recruiting nowThe primary objective of this study is to explore the efficacy and safety of adaptive therapy in the treatment of advanced breast cancer progressive after standard treatment.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Promising combo targets tough leukemia in vulnerable patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if a treatment combination-venetoclax plus hypomethylating agents (like azacitidine or decitabine) and low-dose cytarabine-works to treat adults with newly diagnosed CEBPA-mutated acute myeloid leukemia (AML) who can't tolerate intensiv…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New screening could stop dangerous pregnancy condition before it starts
Prevention Recruiting nowThe goal of this clinical study is to learn if a new first-trimester screening program can better find pregnant women who are at high risk of developing preeclampsia and help prevent the condition with early treatment. Preeclampsia is a pregnancy condition that causes high blood…
Sponsor: Copenhagen University Hospital at Herlev • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
Surgery vs. glue: which seals the deal for anal fistulas?
Disease control Recruiting nowThis study aims to compare ligation of the intersphincteric fistula tract with cyanoacrylate glue in the management of high transsphincteric perianal fistula.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Surgical glue may seal pancreas after cancer surgery, cutting dangerous leaks
Disease control Recruiting nowThis is a single-center, randomized controlled trial comparing the efficacy of pancreaticojejunostomy with modified N-butyl-2-cyanoacrylate(Glubran® 2) versus standard pancreaticojejunostomy without cyanoacrylate in preventing postoperative pancreatic fistula (POPF) in patients u…
Phase 3 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC